Discriminating protective from nonprotective plasmodium-specific CD8+ T cell responses

Journal of Immunology

Volumn 196, Issue 10, 2016, Pages 4253-4262

  Doll, Katherine L ^a   Pewe, Lecia L ^a   Kurup, Samarchith P ^a   Harty, John T ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CIRCUMSPOROZOITE PROTEIN; GLIDEOSOME ASSOCIATED PROTEIN 50; PROTOZOAL PROTEIN; SPOROZOITE SPECIFIC PROTEIN 20; THROMBOSPONDIN RELATED ADHESION PROTEIN; UNCLASSIFIED DRUG; CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; EPITOPE; MALARIA VACCINE; PARASITE ANTIGEN; SUBUNIT VACCINE; THROMBOSPONDIN-RELATED ADHESIVE PROTEIN, PROTOZOAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; INFECTION RESISTANCE; LIVER CELL; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PARASITE LOAD; PHENOTYPE; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPOROZOITE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LIVER; MALARIA; PARASITOLOGY;

ANIMALS; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; FEMALE; HEPATOCYTES; IMMUNIZATION SCHEDULE; IMMUNOLOGIC MEMORY; LIVER; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMODIUM BERGHEI; PROTOZOAN PROTEINS; SPOROZOITES; VACCINES, SUBUNIT;

EID: 84975047639     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600155     Document Type: Article

References (60)

1. Morrison, C. 2015. Landmark green light for Mosquirix malaria vaccine. Nat. Biotechnol. 33: 1015-1016.
2. Agnandji, S. T., B. Lell, J. F. Fernandes, B. P. Abossolo, B. G. Methogo, A. L. Kabwende, A. A. Adegnika, B. Mordmüller, S. Issifou, P. G. Kremsner, et al; RTS, S Clinical Trials Partnership. 2012. A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N. Engl. J. Med. 367: 2284-2295.
3. Olotu, A., G. Fegan, J. Wambua, G. Nyangweso, K. O. Awuondo, A. Leach, M. Lievens, D. Leboulleux, P. Njuguna, N. Peshu, et al. 2013. Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure. N. Engl. J. Med. 368: 1111-1120.
4. Nussenzweig, R. S., J. Vanderberg, H. Most, and C. Orton. 1967. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 216: 160-162.
5. Clyde, D. F. 1975. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg. 24: 397-401.
6. Hoffman, S. L., L. M. Goh, T. C. Luke, I. Schneider, T. P. Le, D. L. Doolan, J. Sacci, P. de la Vega, M. Dowler, C. Paul, et al. 2002. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185: 1155-1164.
7. Schmidt, N. W., N. S. Butler, V. P. Badovinac, and J. T. Harty. 2010. Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS Pathog. 6: e1000998.
8. Schofield, L., J. Villaquiran, A. Ferreira, H. Schellekens, R. Nussenzweig, and V. Nussenzweig. 1987. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330: 664-666.
9. Weiss, W. R., M. Sedegah, R. L. Beaudoin, L. H. Miller, and M. F. Good. 1988. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 85: 573-576.
10. Doolan, D. L., and S. L. Hoffman. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165: 1453-1462.
11. Seder, R. A., L. J. Chang, M. E. Enama, K. L. Zephir, U. N. Sarwar, I. J. Gordon, L. A. Holman, E. R. James, P. F. Billingsley, A. Gunasekera, et al; VRC 312 Study Team. 2013. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341: 1359-1365.
12. Sheehy, S. H., A. J. Spencer, A. D. Douglas, B. K. Sim, R. J. Longley, N. J. Edwards, I. D. Poulton, D. Kimani, A. R. Williams, N. A. Anagnostou, et al. 2013. Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe. PLoS One 8: e65960.
13. McConkey, S. J., W. H. Reece, V. S. Moorthy, D. Webster, S. Dunachie, G. Butcher, J. M. Vuola, T. J. Blanchard, P. Gothard, K. Watkins, et al. 2003. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat. Med. 9: 729-735.
14. Chuang, I., M. Sedegah, S. Cicatelli, M. Spring, M. Polhemus, C. Tamminga, N. Patterson, M. Guerrero, J. W. Bennett, S. McGrath, et al. 2013. DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity. PLoS One 8: e55571.
15. Ewer, K. J., G. A. O'Hara, C. J. Duncan, K. A. Collins, S. H. Sheehy, A. Reyes-Sandoval, A. L. Goodman, N. J. Edwards, S. C. Elias, F. D. Halstead, et al. 2013. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nat. Commun. 4: 2836.
16. Ogwang, C., D. Kimani, N. J. Edwards, R. Roberts, J. Mwacharo, G. Bowyer, C. Bliss, S. H. Hodgson, P. Njuguna, N. K. Viebig, et al; MVVC Group. 2015. Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults. Sci. Transl. Med. 7: 286re5.
17. Sedegah, M., M. R. Hollingdale, F. Farooq, H. Ganeshan, M. Belmonte, Y. Kim, B. Peters, A. Sette, J. Huang, S. McGrath, et al. 2014. Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes. PLoS One 9: e106241.
18. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
19. Chakravarty, S., I. A. Cockburn, S. Kuk, M. G. Overstreet, J. B. Sacci, and F. Zavala. 2007. CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 13: 1035-1041.
20. Cockburn, I. A., S. W. Tse, A. J. Radtke, P. Srinivasan, Y. C. Chen, P. Sinnis, and F. Zavala. 2011. Dendritic cells and hepatocytes use distinct pathways to process protective antigen from plasmodium in vivo. PLoS Pathog. 7: e1001318.
21. Radtke, A. J., W. Kastenmüller, D. A. Espinosa, M. Y. Gerner, S. W. Tse, P. Sinnis, R. N. Germain, F. P. Zavala, and I. A. Cockburn. 2015. Lymph-node resident CD8a+ dendritic cells capture antigens from migratory malaria sporozoites and induce CD8+ T cell responses. PLoS Pathog. 11: e1004637.
22. Bongfen, S. E., R. Torgler, J. F. Romero, L. Renia, and G. Corradin. 2007. Plasmodium berghei-infected primary hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro. J. Immunol. 178: 7054-7063.
23. Cockburn, I. A., R. Amino, R. K. Kelemen, S. C. Kuo, S. W. Tse, A. Radtke, L. Mac-Daniel, V. V. Ganusov, F. Zavala, and R. Ménard. 2013. In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages. Proc. Natl. Acad. Sci. USA 110: 9090-9095.
24. Garg, N., M. P. Nunes, and R. L. Tarleton. 1997. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. J. Immunol. 158: 3293-3302.
25. Montagna, G. N., M. Beigier-Bompadre, M. Becker, R. A. Kroczek, S. H. Kaufmann, and K. Matuschewski. 2014. Antigen export during liver infection of the malaria parasite augments protective immunity. MBio 5: e01321-e14.
26. Florens, L., M. P. Washburn, J. D. Raine, R. M. Anthony, M. Grainger, J. D. Haynes, J. K. Moch, N. Muster, J. B. Sacci, D. L. Tabb, et al. 2002. A proteomic view of the Plasmodium falciparum life cycle. Nature 419: 520-526.
27. Gardner, M. J., N. Hall, E. Fung, O. White, M. Berriman, R. W. Hyman, J. M. Carlton, A. Pain, K. E. Nelson, S. Bowman, et al. 2002. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419: 498-511.
28. + T cell responses to malaria liver stages by genome-wide epitope profiling. PLoS Pathog. 9: e1003303.
29. Howland, S. W., C. M. Poh, S. Y. Gun, C. Claser, B. Malleret, N. Shastri, F. Ginhoux, G. M. Grotenbreg, and L. Rénia. 2013. Brain microvessel crosspresentation is a hallmark of experimental cerebral malaria. EMBO Mol. Med. 5: 916-931.
30. Rogers, W. O., M. D. Rogers, R. C. Hedstrom, and S. L. Hoffman. 1992. Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen. Mol. Biochem. Parasitol. 53: 45-51.
31. Baum, J., D. Richard, J. Healer, M. Rug, Z. Krnajski, T. W. Gilberger, J. L. Green, A. A. Holder, and A. F. Cowman. 2006. A conserved molecular motor drives cell invasion and gliding motility across malaria life cycle stages and other apicomplexan parasites. J. Biol. Chem. 281: 5197-5208.
32. Kaiser, K., K. Matuschewski, N. Camargo, J. Ross, and S. H. Kappe. 2004. Differential transcriptome profiling identifies Plasmodium genes encoding preerythrocytic stage-specific proteins. Mol. Microbiol. 51: 1221-1232.
33. Schmidt, N. W., N. S. Butler, and J. T. Harty. 2011. Plasmodium-host interactions directly influence the threshold of memory CD8 T cells required for protective immunity. J. Immunol. 186: 5873-5884.
34. Schmidt, N. W., R. L. Podyminogin, N. S. Butler, V. P. Badovinac, B. J. Tucker, K. S. Bahjat, P. Lauer, A. Reyes-Sandoval, C. L. Hutchings, A. C. Moore, et al. 2008. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc. Natl. Acad. Sci. USA 105: 14017-14022.
35. Romero, P., J. L. Maryanski, G. Corradin, R. S. Nussenzweig, V. Nussenzweig, and F. Zavala. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341: 323-326.
36. Nussenzweig, V., and R. S. Nussenzweig. 1985. Circumsporozoite proteins of malaria parasites. Cell 42: 401-403.
37. Brockstedt, D. G., M. A. Giedlin, M. L. Leong, K. S. Bahjat, Y. Gao, W. Luckett, W. Liu, D. N. Cook, D. A. Portnoy, and T. W. Dubensky, Jr. 2004. Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc. Natl. Acad. Sci. USA 101: 13832-13837.
38. Lauer, P., M. Y. Chow, M. J. Loessner, D. A. Portnoy, and R. Calendar. 2002. Construction, characterization, and use of two Listeria monocytogenes sitespecific phage integration vectors. J. Bacteriol. 184: 4177-4186.
39. Badovinac, V. P., K. A. Messingham, A. Jabbari, J. S. Haring, and J. T. Harty. 2005. Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11: 748-756.
40. Fan, C., Q. Li, Y. Zhang, X. Liu, M. Luo, D. Abbott, W. Zhou, and J. F. Engelhardt. 2004. IkappaBalpha and IkappaBbeta possess injury contextspecific functions that uniquely influence hepatic NF-kappaB induction and inflammation. J. Clin. Invest. 113: 746-755.
41. Rai, D., N. L. Pham, J. T. Harty, and V. P. Badovinac. 2009. Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J. Immunol. 183: 7672-7681.
42. Butler, N. S., N. W. Schmidt, A. M. Vaughan, A. S. Aly, S. H. Kappe, and J. T. Harty. 2011. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 9: 451-462.
43. Murphy, S. C., A. Kas, B. C. Stone, and M. J. Bevan. 2013. AT-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations. Proc. Natl. Acad. Sci. USA 110: 6055-6060.
44. Doll, K. L., N. S. Butler, and J. T. Harty. 2014. CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii. Vaccine 32: 483-491.
45. Weiss, W. R., J. A. Berzofsky, R. A. Houghten, M. Sedegah, M. Hollindale, and S. L. Hoffman. 1992. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J. Immunol. 149: 2103-2109.
46. Kumar, K. A., G. Sano, S. Boscardin, R. S. Nussenzweig, M. C. Nussenzweig, F. Zavala, and V. Nussenzweig. 2006. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444: 937-940.
47. Grüner, A. C., M. Mauduit, R. Tewari, J. F. Romero, N. Depinay, M. Kayibanda, E. Lallemand, J. M. Chavatte, A. Crisanti, P. Sinnis, et al. 2007. Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS One 2: e1371.
48. Jin, Y., C. Kebaier, and J. Vanderberg. 2007. Direct microscopic quantification of dynamics of Plasmodium berghei sporozoite transmission from mosquitoes to mice. Infect. Immun. 75: 5532-5539.
49. Butler, N. S., N. W. Schmidt, and J. T. Harty. 2010. Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. J. Immunol. 184: 2528-2538.
50. Nolz, J. C., and J. T. Harty. 2011. Protective capacity of memory CD8+ T cells is dictated by antigen exposure history and nature of the infection. Immunity 34: 781-793.
51. Kaech, S. M., E. J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2: 251-262.
52. Harty, J. T., A. R. Tvinnereim, and D. W. White. 2000. CD8+ T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18: 275-308.
53. Cockburn, I. A., S. W. Tse, and F. Zavala. 2014. CD8+ T cells eliminate liverstage Plasmodium berghei parasites without detectable bystander effect. Infect. Immun. 82: 1460-1464.
54. Heath, W. R., G. T. Belz, G. M. Behrens, C. M. Smith, S. P. Forehan, I. A. Parish, G. M. Davey, N. S. Wilson, F. R. Carbone, and J. A. Villadangos. 2004. Crosspresentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199: 9-26.
55. Ebrahimkhani, M. R., I. Mohar, and I. N. Crispe. 2011. Cross-presentation of antigen by diverse subsets of murine liver cells. Hepatology 54: 1379-1387.
56. Shen, H., J. F. Miller, X. Fan, D. Kolwyck, R. Ahmed, and J. T. Harty. 1998. Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell 92: 535-545.
57. Kwok, L. Y., S. Lütjen, S. Soltek, D. Soldati, D. Busch, M. Deckert, and D. Schlüter. 2003. The induction and kinetics of antigen-specific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis. J. Immunol. 170: 1949-1957.
58. Gubbels, M. J., B. Striepen, N. Shastri, M. Turkoz, and E. A. Robey. 2005. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infect. Immun. 73: 703-711.
59. Agnandji, S. T., B. Lell, S. S. Soulanoudjingar, J. F. Fernandes, B. P. Abossolo, C. Conzelmann, B. G. Methogo, Y. Doucka, A. Flamen, B. Mordmüller, et al; RTS, S Clinical Trials Partnership. 2011. First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. N. Engl. J. Med. 365: 1863-1875.
60. Hoffman, S. L., P. F. Billingsley, E. James, A. Richman, M. Loyevsky, T. Li, S. Chakravarty, A. Gunasekera, R. Chattopadhyay, M. Li, et al. 2010. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum. Vaccin. 6: 97-106.